Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Chembio SCoV-2 Ag Detect™ Rapid Test Kit
SDP

The SCoV-2 Ag Detect Rapid Test Kit can be used for testing symptomatic or asymptomatic patients using a direct nasal sample that gives results in about 20 minutes.

Supplier:  Chembio 9020218

 View more versions of this product

Catalog No. 23-999-116

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

View Alternate Product

Explore available promotions
This item is not returnable. View return policy

Description

Description

SCoV-2 Ag Detect™ Rapid Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
  • Easy to use POC SARS-CoV-2 Nucleoprotein antigen test that can performed in many settings with symptomatic or asymptomatic patients
  • Identifies acute infection in symptomatic patients with high accuracy: PPA (Sensitivity) 86.67%, NPA (Specificity) 100%
  • Direct nasal sample
  • Results in approximately 20 minutes
  • No instrumentation needed
Specifications

Specifications

15°C to 30°C
Waived
Direct Nasal Swab
SARS-CoV-2 Rapid Antigen Test
Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
50 Tests/Kit
1
Liquid
Yes
SARS-CoV-2 Antigens
0.8667
Single-use
Pouched cassettes, 1 positive control, 1 negative control, sterile swabs, lysis buffer
Human
20 Min.
Safety and Handling

Safety and Handling

ShelfLife : 6 Months

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.